Root Financial Partners
SLDB icon

Root Financial Partners’s Solid Biosciences SLDB Stock Holding History

Root Financial Partners’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7 Buy
+1
New +$9 ﹤0.01% 3808

Other funds holding SLDB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Root Financial Partners's SLDB Position: Q3 2026 in Review

Root Financial Partners opened a new position in Solid Biosciences (SLDB) in Q3 2026: 1 share worth $7. The stake represents ﹤0.01% of the portfolio and ranks #3808 among its holdings.

57 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • Root Financial Partners held 1 share of Solid Biosciences worth $7 as of Q3 2026.
  • Solid Biosciences was a new Root Financial Partners position in Q3 2026.
  • Solid Biosciences made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3808 holding.
  • 57 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.